The relationship between baseline health and longitudinal costs of hospital use. by Wouterse, B. et al.
HEALTH ECONOMICS
Health Econ. (2010)
Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/hec.1664
THE RELATIONSHIP BETWEEN BASELINE HEALTH
AND LONGITUDINAL COSTS OF HOSPITAL USE
BRAM WOUTERSE
a,b,, BERT R. MEIJBOOM
a and JOHAN J. POLDER
a,b
aScientiﬁc Center for Transformation in Care and Welfare (TRANZO), Tilburg University, Tilburg, The Netherlands
bNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
SUMMARY
In this paper, we investigate the relationship between baseline health and costs of hospital use over a period of eight
years. We combine cross-sectional survey data with information from the Dutch national hospital register. Four
different indicators of health (self-perceived health, long-term impairments, ADL limitations and comorbidity) are
considered. We ﬁnd that for ages 50 to 70, differences in hospital costs between good health and bad health are
substantial and persist during the whole time period. However, for higher ages expected hospital costs for
individuals in bad health decline rapidly and become lower than those for people in good health after about six to
seven years. The higher mortality rate among people in bad health is the primary cause here. Our results are
conﬁrmed for all four health indicators. We conclude that relying on better health to contain healthcare
expenditures is too optimistic, and the interaction between health and mortality should be taken into account when
projecting healthcare costs. Healthy ageing is important, but more for health gains than for cost savings. Copyright
r 2010 John Wiley & Sons, Ltd.
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1. INTRODUCTION
The ageing of the population in most Western countries is an important issue in policy debate. The
increase in the share of elderly in these countries, as a result of decreased fertility rates and increasing
life expectancy, will put pressure on public ﬁnances. Healthcare use is highly correlated with age,
therefore the budgetary effects of ageing are especially relevant in the health care sector. Because it has
often been suggested that a part of the cost raising effects of ageing can be offset by an increase in
general health, insight in the longitudinal relationship between health and costs of health care use is
needed. The inﬂuence of health on costs of health care comprises two opposing components: better
health is associated with lower costs per life year but also with additional costs associated with a higher
remaining life expectancy. There is strong evidence of increasing trends in life expectancy, but the
ﬁndings on trends in health and prevalence of chronic diseases are much less clear (De Hollander et al.,
2006; Fries, 2005; Luepker, 2006; Mackenbach et al., 2008; Robine and Michel, 2004).
The inﬂuence of trends in health on costs of healthcare use are assessed in a number of studies
(Michaud et al., 2009; Manton et al., 2007; Singer and Manton, 1998; Westerhout and Pellikaan, 2005).
However, the relationship between health status, mortality and costs of healthcare use is seldom directly
taken into account. Lubitz et al. (2003) do estimate this relationship using multistate lifetable
techniques. They ﬁnd that at 70 years of age, individuals with limitations in activities of daily living have
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Copyright r 2010 John Wiley & Sons, Ltd.a considerably lower life expectancy than individuals in good health, but the cumulative healthcare
expenditures over their remaining life are almost equal. This result seems to indicate that better health
will not necessarily lead to lower cost of healthcare use. Instead, the role of a longer life expectancy and
postponement of costs to a later age may be more important.
This paper investigates the longitudinal relationship between health status and costs of hospital use
in the Netherlands. We aim to provide the following contributions: First, we investigate the relationship
between health and costs of hospital use over a time period of 8 years. We use survival analysis to relate
initial health status to costs of hospital use in following yearly periods. In contrast, Lubitz et al. (2003)
and Michaud et al. (2009) ﬁrst relate costs of hospital use to current health status and then use Markov
techniques to model transitions in health state. By directly estimating costs as a function of initial
health, we avoid the possibly restrictive Markov assumption of duration independent transitions. There
is evidence that the probability of returning to good health is smaller if the time spent in bad health is
longer, and that transitions in health are indeed not independent of duration (Burchardt, 2000; Cai
et al., 2006; Crimmins et al., 1994).
Second, we look at the relationship between health status and hospital costs for different age groups
of people older than 50. Lubitz et al. (2003) focus on healthcare expenditures for individuals at the age
of 70 years, but cost differences between health states at other ages might well show different results.
The effect of initial health on mortality and hospital use, especially over a longer period of time, can be
age- and sex dependent. For example, at higher ages initial health state might be less informative of
future hospital costs, because the probability of becoming less healthy is higher than at lower ages.
Third, we estimate the relationship between health and hospital costs for different indicators of
health (self-perceived health, long-term impairments, ADL and comorbidity). The relationship between
health and costs may depend on the chosen measure. For instance, Cesari et al. (2008) ﬁnd differences in
performance between physical functioning and self-rated health in predicting mortality. The differences
between indicators could also be age- and sex-speciﬁc and duration dependent.
We use eight years of Dutch cross-sectional health survey data and link this data to the Dutch
National Medical Registration and the Causes of Death Statistics over the same period. This linkage
allows us to estimate the relationship between health status, hospital use, and mortality over a
maximum period of 8 years. We use a three-part model, modeling the probability of survival, the
conditional probability of hospital use and the conditional costs of hospital use separately. Although
there are a number of studies that use two- or three-part models for (semi-) continuous data, for
example (Liu, 2009; Olsen and Schafer, 2001; Tian and Huang, 2007), to our knowledge this is the ﬁrst
implementation of such a model in a discrete survival context.
2. METHODS
2.1. Three-part model
We want to relate health status and background characteristics of an individual at a certain time t0 to
costs of hospital use in the following consecutive yearly periods after t0. Let hi,k be the total costs of
hospital care use of individual i during period tkrtotk11, where k50,1,y,K coincides with yearly time
intervals. To relate hi,k to survival probability and health status, we start from a two-part model (Duan
et al., 1983) in which the probability of hospital use is modeled separately from the conditional costs of
hospital use. This two-part model is extended with an additional part, modeling the probability of
survival up to time tk. This modeling strategy is used for two reasons: First, it allows us to separately
identify the relationship between health and survival, health and probability of hospital use, and health
and costs of hospital use. Second, modeling the probability of hospital use and costs of hospital use
separately accounts for excess zeros: the number of people not using any hospital care during
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with, for example, a Poisson distribution.
The aim of our study is to estimate the overall inﬂuence of differences in health status on longitudinal
hospital costs. Therefore, we use a marginal modeling framework (Lu et al., 2004) for the three-part
model. The resulting estimates provide population averaged effects, in the sense that they show the
average difference in hospital costs between individuals in different health states. This is often the
relevant viewpoint from a policy or societal perspective (Liu et al., 2010). It can be expected, for
example based on the well-known relationship between time to death and healthcare expenditures, that
the different parts of the three-part model are correlated. The use of the marginal model implies that we
do not model that correlation. An alternative model speciﬁcation, which does take this inter-part
correlation into account, would be a random effects model with correlated random effects between the
different parts, for example applied by Liu (2009). As noted by Albert (2005), the marginal model
and the correlated random effects model can yield different parameter estimates, when correlation
between the parts indeed exists. Which model is correct again depends on the aim of the study. For
example, the marginal model estimates of the third part of our three-part model for period k are
estimates of the inﬂuence of health status on the conditional hospital costs for the individuals who
actually went to the hospital in period k. Instead, the random effects estimates provide the effect of
health status on conditional expenditures for an average individual from the total population. In
accordance with the societal perspective of our study, the marginal model seems to be justiﬁed. For the
same reason, we opt for the two-part model framework instead of a heckit model, because we consider
the zeros to be actual outcomes and not censored ‘potential’ outcomes. As argued by Dow and Norton
(2003), such an independent two-part model is often more appropriate for estimating real outcomes
than inﬂated zero- or heckit models.
In the data, survival is observed in discrete time intervals. Therefore, we apply a discrete survival
analysis approach to the three-part model. The ﬁrst part of the model concerns the probability of being
alive at time tk.L e tTi be the duration of the time an individual is alive, then we use the following discrete
time transition model (Cameron and Trivedi, 2006) for the probability of being alive up to time tk:
PðTi   tkjTi   tk 1;xi;tkÞ¼F1ðx0
i;tkbtkÞð 1Þ
For F1, we use the logistic cumulative density function. We condition the probability of being alive at
tk on being alive at time tk–1, which means that we model the probability of surviving during period
tk–1rto tk. The parameters as well as the x vectors have a time subscript. This time dependence is
discussed in Section 2.3. Equation (1) can be estimated by using a stacked data design: separate
observations are constructed for each discrete time period during which individual i is alive and one
observation for the period in which he or she dies. A dummy variable is added, indicating whether the
individual i stays alive or dies during the period under consideration.
We formulate the second part of the model, the probability of hospital use, as
Pðhi;k40jTi   tk;xi;tkÞ¼F2ðx0
i;tkbtkÞð 2Þ
The probability of hospital use during tkrto tk11 is expressed conditional on being alive up to time
tk. For F2, we again use the logistic cdf. The third part of the model is the expected hospital use given
any hospital use in period k. For this part, a general linear model is used:
Eðhi;kjhi;k40;xi;tkÞ¼gðx0
i;tkbtkÞð 3Þ
The function g( ) links the linear relationship between the covariates x0
i;tkbtk to expected hospital use.
The choice of this link function is discussed in Section 2.2.
The three parts of the model can be combined to get the unconditional expectation of costs of
hospital use in period tkrtotk11:
Eðhi;kjxi;tkÞ¼Eðhi;kjhi;k40;xi;tkÞ Pðhi;k40jTi   tk;xi;tkÞ Siðtk;xi;tkÞ: ð4Þ
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PðTi   tjjTi   tj 1;xi;tjÞð 5Þ
Expected cumulative costs over longer discrete periods of time can be calculated by summing over the





To obtain conﬁdence intervals for predicted survival, probability of hospital use, conditional- and
unconditional costs of hospital use, we use bootstrapping. To preserve the correlation between
longitudinal observations of the same individuals, we perform the bootstrap procedure with clustering
observations on an individual level. The models for each indicator and their three separate parts are all
estimated within the same sample. We use 1000 bootstrap runs.
2.2. Choosing the functional form
The third part of our model, concerning the conditional costs of hospital care in period k, is formulated
as a general linear model (GLM). The reason for this formulation is that we expect the data to have
thick right tails. Instead of log transforming the data, the GLM approach avoids transformation issues
by directly modeling E(y) as a possibly nonlinear function of x. For notational convenience, let
yi,tk   E(hi,k|hi,k40,TiZtk)a n dg5g
 1 so that we can rewrite Equation (3) as
g ðyi;tkjxi;tkÞ¼x0
i;tkbtk ð7Þ
The GLM approach requires the choice of the link function g( ) as well as a function for the
variance of yi,tk. The link function determines the transformation of yi,tk. For example, the log-link
models a linear relationship between log(yi,tk) and xi,tkbtk:
g ðyi;tkjxi;tkÞ¼logðyi;tkjxi;tkÞ¼x0
i;tkbtk ð8Þ
To determine the appropriate link function, we use a Box-Cox test. We limit our choice of variance
functions to the class of power-proportional variance functions, which describe the relationship between
Var(yi) and the mean as
Varðyi;tkÞ¼ym
i;tk ð9Þ
where m is an integer. Different values of m coincide with well-known functional forms. For example,
m51 is equivalent to a Poisson distribution and m52 is equivalent to a Gamma distribution. We use
the modiﬁed Park test described by Manning and Mullahy (2001) to determine m.
2.3. Duration dependence
The formulation of the three-part model allows for time varying covariates as well as parameters.
In case of the covariates, we use the values at time t0. The reason for keeping the values at their initial
level is that the model is forward looking or predictive: it estimates expected costs of hospital use in
following periods based on information on current health status. We do correct for calendar year
effects, caused by changes in budget constraints imposed by the government and other autonomous
inﬂuences, by including calendar year dummies.
The effect of the health variables is allowed to change over time, by using duration-dependent
parameters. The parameters of the other background variables are kept constant. In regard to the time
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tk consists of the calendar year dummies.
The duration dependence of b
a
tk can be introduced by using a separate coefﬁcient for each period.
However, this would drastically increase the number of parameters in the models. To keep the model








The order of the polynomial n is determined by assessment of model ﬁt, based on AIC and BIC values
and Likelihood Ratio tests. Because a stacked data set is used, in which a separate individual observation
is available for each period k, the inclusion of time-dependent parameters is straightforward.
3. DATA
3.1. General description of the data
The data used in this research are part of the Social Statistics Database (SSB)
1 of Statistics Netherlands
(CBS). The SSB consists of a collection of several independent surveys and registrations. At the core of
the SSB is the Municipal Population Registration (GBA), which contains basic information like date of
birth and registered partners for everyone enlisted in a Dutch municipality. Databases in the SSB, can
be linked to the GBA by means of an anonymized identiﬁcation key. Using this key, it is possible to link
information from different sources at an individual level. We use three data sources from the SSB: the
Statistics Netherlands Integrated System of Social Surveys (POLS), the Dutch Causes of Death
Statistics (DO) and the Dutch Hospital Discharge Register (LMR). The POLS survey consists of a basic
survey and several modules, which cover a speciﬁc subject in more detail for different parts of the total
POLS population. One of these modules is the POLS health survey. This health survey is a
representative sample survey containing detailed information on health and healthcare use for
approximately 10,000 individuals per year. We use the survey years 1997–2005. The Causes of Death
Statistics is a register covering all deaths in the Netherlands. The Dutch Hospital Discharge Register
(LMR) is provided by the Prismant healthcare services institute. All university and general hospitals
and most specialized hospitals participate in the LMR. Therefore, the data set provides a nearly
complete coverage of all hospital inpatient treatments in the Netherlands. All clinical and day
admissions are registered based on a uniform registration system. The data include admission and
discharge dates, and extensive treatment and diagnosis information on ICD-9 level.
We construct our data set by linking a particular POLS health survey year to consecutive years of the
DO and LMR registers up to 2005. Linkage of POLS to the Causes of Death Statistics and LMR
enables us to estimate mortality and hospital use for the POLS population in the years following the
survey. For an individual from the 1997 survey, we can follow hospital use and mortality over a
maximum of 9 years (1997–2005). However, for an individual from the 2005 survey, we can follow
hospital use and mortality over a maximum of only 1 year. We deﬁne a period k as the k–1th year after
the month an individual is interviewed in the POLS health survey. The POLS survey is organized in such
a way that interview dates are equally spread over all months. Because we use yearly periods, only a
small number of individuals can be followed over nine years (only the individuals interviewed in
1http://www.cbs.nl/nl-NL/menu/informatie/onderzoekers/ssb/ssb-info-medio-07.htm.
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which a period is deﬁned is illustrated in Figure 1: the upper line shows individual A who is interviewed
in February 1997 and who’s hospital use can therefore be followed over eight yearly periods. As shown,
the periods k generally do not coincide with calendar years. The second line in Figure 1 shows individual
B who is interviewed in October 2001 and can therefore be tracked over four periods.
The LMR records do not contain a unique personal identiﬁcation key, which would enable direct
linkage to the POLS surveys. Instead, Statistics Netherlands provides a constructed identiﬁcation key.
This key is based on a linkage of records in the LMR to the Municipal Population Registration (GBA)
by postal code, date of birth, gender and admission date. About 15% of the POLS population cannot be
uniquely identiﬁed by this procedure. Because of removal to an area with another postal code or
changing characteristics, identiﬁability can change over time. Individuals are only included in the
estimation over the periods in which they are uniquely linkable. The procedure is illustrated by
individuals C and D in the lower part of Figure 1. The two individuals are the same as for the lines on
top, only they cannot be uniquely linked in all periods (indicated by the dotted lines).
Table I provides an overview of the population of the combined data set for each period. The
population is categorized according to age and health status for the four indicators of health that are
used in our subsequent analysis (Section 3.4). Age groups below 50 are not included in the table, because
not all indicators of health are available for those groups. The number of people in each category is
reported as well as the percentage of uniquely linkable individuals (in brackets). The probability of
being uniquely linkable seems to increase with age, while the probability is rather stable over periods
and between health states.
3.2. Censoring bias
Because of the different interview dates and the linkage procedure, a part of the data is censored: the
hospital use of most individuals cannot be observed over the full evaluation period (eight years). If this
censoring is not independent of hospital use, at least conditional on the x variables in the three-part
Figure 1. An illustration of the design of the data. Period k is deﬁned as the kth year after the interview date. The
two upper cases concern two individuals A and B. A is interviewed in POLS in January 1997 and his hospital use
can therefore be observed for eight yearly periods, k50,y,7. B is interviewed in June 2001, and his hospital use can
be observed over four yearly periods k50,y,3. The two lower cases concern individuals C and D who’s hospital
use is censored during a part of the observation period
B. WOUTERSE ET AL.
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independence assumption does not hold (Bas -er et al., 2006; Lin, 2003). The argument is that individuals
who survive during the whole evaluation period are at risk of being censored during a longer period of
time than individuals who die during the evaluation period. Because hospital costs are known to be
higher for deceased than for survivors (Zweifel et al., 1999), ignoring this difference may bias cost
estimates upward.
The ﬁrst cause of censoring, the different interview dates, does not lead to estimation bias.
As illustrated by Figure 1, individuals are only included for the yearly time intervals that end
before 2006. For example, if individual B would die in November 2005, his observation for k54
would not be included. Since censoring in this case is determined only by interview date, it is random
and therefore does not inﬂuence the estimates. In contrast, the linkage procedure could lead to
estimation bias: individuals who die during a period tkrtotk11 have a higher probability of being
linked to the LMR than individuals who survive up to time tk11. The probability of unique linkage is
known to depend on characteristics like age, income and ethnicity (De Bruin et al., 2003), but because
the model includes socioeconomic background variables this is not a problem. However, it is not
unlikely that the probability of linkage is also dependent on survival probability. Therefore, we test
whether individuals who die during period k have a higher probability of being uniquely linked than
survivors.
3.3. Assigning costs
Costs per admission are not supplied in the data set, but are calculated by using data from the Dutch
Costs of Illness Study (Slobbe et al., 2006). In this general cost of illness study, total healthcare
expenditure are assigned to diseases and patient characteristics. For hospital expenditure, a combined
top–down and bottom–up approach is used. Total hospital expenditure is known from national
health accounts and can be broken down to inpatient and ambulatory care, respectively, using data
from the Dutch hospital budget system. In this paper, we focus on inpatient care including all clinical
procedures and day cases, comprising 60% of total hospital expenditure. Costs per admission are split
up into two parts: intervention costs and all other costs associated with hospital stay. As all
interventions are registered in the LMR in ICD-9 format, intervention costs per patient can be
calculated using the detailed remuneration schemes of the Dutch hospital payment system. This scheme
provides for each intervention all relevant doctor’s fees and the hospital’s reimbursement for associated
costs of, among others, equipment, materials and personnel. All other costs of hospital stay, like nursing
and accommodation costs, are calculated on a daily basis, using average per diem costs. Costs are
aggregated per admission.
3.4. Indicators of health
We use four different measures of health status: self-perceived health status, long-term impairments,
limitations in Activities of Daily Living (ADL), and comorbidity. For each measure, we construct an
indicator with three levels based on associated questions in POLS. The indicator for self-perceived
health status is based on one question in which individuals are asked to describe their own health in
terms of ﬁve answer categories. However, in 2001, the deﬁnition of the answer categories has been
changed. This change causes a break in the trends for the lowest three categories. Therefore, we combine
the lowest three categories into one new category that does not show a trend break (Botterweck et al.,
2003). The classiﬁcation of long-term impairments is based on parts of an OECD questionnaire
included in the POLS survey. The questions and constructed indicators for each measure are reported
in Table II.
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The three-part model for the relationship between health and costs of hospital use is estimated for each
indicator of health separately. The same set of explanatory variables is used for all indicators and for
each part of the three-part model. The relationship between sex, age and health is introduced as a three-
way interaction effect, using dummies for each three-way category. The parameters of these three-way
interactions are duration dependent. The other included covariates are a series of calendar year
dummies and a series of dummy variables for the highest attained education level. A dummy variable
for ethnicity was dropped, due to a lack of signiﬁcance. A logit model, including the same set of
variables as the three-part model and a dummy for dying, has been used to test whether linkage to the
hospital register during a certain period depends on surviving that period. No signiﬁcant effect of
survival on linkage probability has been found. Therefore, we decide not to use correction weights in the
three-part models.
Results from the Box-Cox test for different speciﬁcations of the model indicate that the log-link
provides the best ﬁt to the data. To determine the functional form of the third part, the GLM model for
conditional costs of hospital use, we perform the modiﬁed Park test. The test indicates a quadratic
relationship between mean and variance, equivalent to the Gamma family, for all indicators of health.
Assessments of ﬁt based on AIC and BIC criteria and likelihood ratio tests show a better ﬁt for the
models with linear duration dependence than constant duration dependence. The results are less clear
Table II. Indicators of health in POLS: questions, answers and elements of the constructed categories used
Measure Questions Answers Levels
Self-perceived
health
How would you describe your own health? very good 1. very good
good 2. good




follow a conversation in a group of 3 or more persons? yes, without difﬁculty 1. yes, without difﬁculty
have a conversation with one person? with minor difﬁculty 2. at least one minor difﬁculty
read the small print in the newspaper? with major difﬁculty 3. at least one major difﬁculty
recognize a face at a distance of four meters? unable to do
carry an object of 5 kilograms for 10 meters?
bend down and pick up something from the ﬂoor?




eat and drink? yes, without difﬁculty 1. yes, without difﬁculty
get up from a sitting position? with minor difﬁculty 2. at least one minor difﬁculty
get in- and out of bed? with major difﬁculty 3. at least one major difﬁculty
dress and undress? only with aid
transfer to another room on the same ﬂoor?
climb up and down the stairs?
enter and leave the house?
transfer outdoors?
wash face and hands?
bath?
Comorbidity Occurrence in the last 12 months 1. no disease
asthma 2. one disease
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model, a quadratic duration dependence seems to provide a somewhat better ﬁt than linear dependence.
To keep the models parsimonious and comparable, between parts and between indicators of health, we
use linear duration dependence for all models. The regression results for each health indicator, including
the values of the information criteria and the LR tests, are reported in Appendix A. In each table, the
coefﬁcients and p-values for all the three parts of the model are shown. The three-way dummies have
two coefﬁcients: one for the time constant, or baseline effect, and one for the time varying effect. For
age, we use ten-year groups from 50 onwards.
We use the estimated parameters in Appendix A to make predictions of survival, probability of
hospital use, conditional- and unconditional costs of hospital use. Separate predictions are made for
each combination of sex, age and health, while keeping the other background variables at their baseline
level (education level is low and evaluation year is 1997). Figures 2–5 show the predictions and
bootstrapped 95% conﬁdence intervals for self-perceived health status. Figure 2 shows the survival up
to period k, which is constructed by multiplying the survival probabilities for each period up to k as
described in Equation (5). Survival is consistently lower for individuals in bad health compared
with the individuals with the same age and sex in good health. The graphs also show a negative
correlation between age and survival, and lower survival for men than for women with the same age
and health.
The predicted probability of hospital use in period k conditional on being alive at the start of period
k is shown in Figure 3. The probability of hospital use in the ﬁrst period increases with worsening health
state. The initial probability of hospital use also shows a correlation with age, but the sex differences are
limited. Considering the time patterns, the differences in probability of hospital use seem to be rather
constant over time for the age groups 50–60 and 60–70 years. For the two oldest age groups, there is
convergence in probability of hospital use over time. For men older than 80 and women older than 70,
Figure 2. Part 1 for perceived health status: predicted probability of being alive in a period k and bootstrapped
95% conﬁdence intervals
B. WOUTERSE ET AL.
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DOI: 10.1002/hecFigure 3. Part 2 for perceived health status: predicted probability of any hospital use in a period k given alive in
period k and bootstrapped 95% conﬁdence intervals, by health state
Figure 4. Part 3 for perceived health status: predicted costs (euro) of hospital use in a period k given any hospital
use in period k and bootstrapped 95% conﬁdence interval, by health state
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DOI: 10.1002/hecthe probability of hospital use given initial bad perceived health declines over time, whereas the
probability of hospital use given excellent health between 70–80 increases.
The costs of hospital use conditional on having any hospital use in period k, displayed in Figure 4,
are higher for individuals with bad perceived health than individuals in good perceived health. For bad
health in the young age groups, the conditional costs of hospital use show a sharp increase over time. At
higher ages, the differences again show some convergence over time.
Multiplying survival, probability of use and conditional costs of hospital use as in Equation (4),
yields the unconditional predictions of hospital use for each period k in Figure 5. It appears that the
levels of expected hospital use in the ﬁrst period increase with age, but the relative differences between
bad health and good health remain relatively stable. At lower ages, the differences in expected hospital
use are quite persistent over time. At higher ages, the expected hospital use for individuals in bad health
decreases over time, whereas the hospital use for individuals in good and excellent health remains stable
or even increases. As a result, for the highest male age group, the expected hospital use is higher for
individuals in excellent health than individuals in bad health in 6 and 7 years after measurement of
health.
For the other three indicators, being long-term limitations, limitations in activities in daily living
and comorbidity, we only show the unconditional predictions in Figures 6–8. The same general patterns
seem to occur for all indicators. For younger age groups, differences in costs between good and bad
health are relatively stable over time. For older age groups, the expected costs of individuals in bad and
in good health converge over time. In case of major long-term impairments, shown in Figure 6, this
convergence is already visible for men between 60 and 70 years. In contrast, for women this convergence
only occurs for the oldest age group. The costs of men between 50 and 60 years with major ADL
limitations (Figure 7) show an increasing time pattern, whereas the costs for women with the same age
Figure 5. Total for perceived health status: predicted costs (euro) of hospital use in a period k, by health state.
Bootstrapped 95% conﬁdence intervals
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Figure 6. Predicted costs (euro) of hospital use, long-term impairments, by health state. Bootstrapped 95%
conﬁdence intervals
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Figure 9. Cumulative costs (euro) of hospital use over eight periods by different levels of health (1, 2 and 3) for
different measures of health status. The different health states are described in Table II
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an outlier effect. For the other age groups, the initial differences between no impairments and
major impairments are larger for men than for women. The expected costs of individuals with major
impairments in the two oldest age groups are lower than the costs of individuals without initial
impairments, after 6–7 years. The costs of hospital use for comorbidity, in Figure 8, again show the
same converging pattern over time for the oldest age group.
The expected costs over all eight periods (cumulative costs) are shown in Figure 9. For the age
groups of 50–60 and 60–70 years, the cumulative costs rise with worsening health for each indicator.
For the older age groups, the cumulative costs for people in bad health are still higher than for people
in good health, but the pattern is less strong. For instance, in the case of comorbidity, the relative
differences are much smaller at older ages compared with the differences at younger ages. The
cumulative costs for men older than 80 years with moderate perceived health are lower than the costs
for men of the same age with excellent health. The cumulative costs for women in the highest age
category are also higher with no comorbidity than with moderate comorbidity. Women older than
80 years with severe ADL limitations have lower cumulative costs than women with only moderate
ADL limitations.
Table III shows the difference in cumulative costs between excellent and bad health, for each
indicator and age- and sex group. Bootstrapped 5% signiﬁcance levels are also provided.
The differences in cumulative costs increase with age for men in case of long-term impairments, and
decrease for men in case of ADL. All the other groups ﬁrst show an increase in cumulative costs
between 50 and 70/80 and then a decline. In four cases of the oldest age group the difference
in cumulative costs is not signiﬁcantly different from zero at a 5% signiﬁcance level: self-perceived
health and comorbidity for men, and long-term impairments and comorbidity for women. Table III
also shows which part of the cost difference is due to increased intensity (where survival is kept at
the level of good health), and which part is due to the lower survival probability of individuals in
bad health. The diminishing effect of survival on cost differences increases with age, and is larger for
men than for women.
Table III. Differences in cumulative costs (h), over the ﬁrst 8 years after the measurement of health state, between
the worst health state and best health state
Men Women
Indicator Age Total Const. surv. Survival Total Const. surv. Survival
Perc. health 50–60 5604 5699 95 5930 5969 39
60–70 11537 12162 625 8290 8498 208
70–80 12313 14521 2208 7430 7937 508
480 7693 11623 3929 5875 6608 733
Long-term imp. 50–60 6117 6178 61 4898 4921 23
60–70 6180 6437 256 9865 10017 152
70–80 7614 9591 1978 6274 6713 438
480 9785 12214 2429 5670 6571 902
ADL 50–60 22922 23580 657 11319 11478 160
60–70 16909 18936 2026 15972 16599 627
70–80 12395 17027 4632 7444 8322 879
480 10166 16785 6619 4454 5815 1361
Comorbidity 50–60 6663 6750 87 3649 3661 12
60–70 8965 9310 345 10577 10742 165
70–80 10927 14276 3348 6025 6444 420
480 5761 10047 4287 6262 7112 849
The total difference (total) is split up into a part due to difference in intensity, keeping survival at the good health level (const.
surv), and the difference due to the lower survival for bad health (survival). Numbers in bold are not signiﬁcantly different from
zero (5% signiﬁcance level, bootstrapped).
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In this paper, we have analyzed the longitudinal relationship between health status and costs of
hospital use in the Netherlands. Initial health status has been related to costs of hospital use in the
following 8 years using a three-part model, estimating survival, probability of hospital use and costs
of hospital use separately. We have estimated costs using four different indicators of health and
several age groups. Our main ﬁnding is that for age groups up to 70 years, bad health leads to higher
costs of hospital use and the difference between bad and good health is generally persistent over an
8-year period. For higher age groups, however, a different pattern arises: mostly due to higher
mortality, the expected costs of individuals in bad health show a decreasing pattern, resulting in lower
expected costs after 6–8 years compared with individuals in good health. This result is found for all
four indicators of health.
The effect of health in the three part models is modeled with a linear time dependency. The regression
results in Appendix A show that not all time-dependent parameter are signiﬁcant (at a 5% level).
Because one of our goals is to explicitly describe the time dependency of initial health on hospital costs,
we decided to keep the not signiﬁcant time-dependent parameters in the models. The most striking
example of duration dependence is the effect of excellent perceived health on probability of hospital
use, shown in Figure 3. For the ages of 50–80 years, the probability of hospital use shows an increase
over time for individuals in excellent health. There seems to be a postponement effect: in the long-run
better health does not lead to lower hospital use, but merely to a postponement of hospital use to a later
period in time.
The results on age effects are in line with what is expected: older age leads to higher mortality, higher
conditional probability of hospital use, and higher conditional costs of hospital use. Considering the
cumulative costs over 8 years, the generally higher costs for ages 60–70 years compared with ages 50–60
indicate that between ages 50 and 70 the effect of mortality on costs is relatively small. But after age 70,
the cumulative costs are more or less constant, implying that the age effect on increasing costs is
mitigated by the age effect on mortality. As shown by the split up of costs due to difference in intensity
and differences in survival, the lower survival probability of people in bad health has a large lowering
inﬂuence on the costs difference with people in good health at higher ages. This effect is stronger
for men than for women, due to the greater differences in survival between health states for men.
Interestingly, the higher life expectancy of women compared with men does not lead to higher
cumulative costs.
The general patterns are the same for the different indicators of health, but the results also show
some relevant differences. At ages 50–70, the differences in cumulative costs between best and worst
health state are considerably higher for ADL than for the other indicators, due to the high costs
associated with major ADL impairments. Even at older ages, major ADL impairments are associated
with higher costs than the worst health states of the other indicators. However, as major ADL
impairments are also associated with higher mortality at older ages, the difference in cumulative costs
between best and worst health state is much more similar to the other indicators. This result shows the
importance of choice of health indicator and the interactive effect of health and age on healthcare costs
as well as survival.
We have opted for the use of a marginal model framework instead of a random effects model, in
which correlation between the different parts of the models is explicitly modeled (Liu, 2009; Liu et al.,
2010). The marginal model was chosen because of the interest in the population averaged effects. As
noted by Liu et al. (2010), random effects models can also be used to estimate population average effects
by averaging over the distribution of the random effects. In case the individual effects indeed follow the
distribution speciﬁed by the correlated random effects model, this model might yield more efﬁcient
population averaged estimates. However, in general the marginal model seems to be more robust to
speciﬁcation errors.
B. WOUTERSE ET AL.
Copyright r 2010 John Wiley & Sons, Ltd. Health Econ. (2010)
DOI: 10.1002/hecAlthough costs of hospital use are observed over all periods, health status is only observed at the
beginning of the ﬁrst period. As a result, the individual costs of hospital use cannot be directly related to
changes in health status over time. The declining patterns of expected costs of low health at older ages
seem to indicate that the expected hospital costs over remaining lifetime may well be lower for individuals
in bad health than individuals in good health. Therefore, relating hospital costs directly to changes in
health status over time and simulating costs over the remaining lifetime seem to be fruitful future
extensions. At least, when duration dependence in transition probabilities is accurately dealt with.
This paper is limited to costs of hospital use. Hospital care is an important part of health care, but for
other parts of care different results may be found. Especially relevant at old ages is institutional or long-
term care, where substitution with hospital care may occur. The trade off, in terms of costs, between annual
costs and life expectancy, will most likely also be present in other parts of the healthcare sector. However,
the relative inﬂuence of these opposing components may be different from that in hospital care. For
example, in a cross-sectional study, De Meijer et al. (2009) ﬁnd that after controlling for disability, age is
still a signiﬁcant determinant of long-term care. This might suggest that the inﬂuence of longer life
expectancy is even larger in long-term care than in hospital care. However, to assess whether this is indeed
the case, longitudinal research on the relationship between health status and long-term care costs is needed.
6. CONCLUSIONS
The ageing of the population will put pressure on healthcare expenditures. The improvement of health
status is often seen as an instrument to contain the costs of health care. Therefore, insight into the
longitudinal relationship between health and costs of healthcare use is necessary. In this paper, we have
investigated the relationship between different indicators of health and costs of hospital use in the
Netherlands over a period of 8 years. We have found that for the relatively younger age groups, between
ages 50 and 70 years, baseline good health is persistently associated with low expected costs of hospital
use in comparison with bad health over an 8-year period. At higher ages, the initial lowering effect of
good health on costs seems to be counteracted over time by lower mortality.
Improvement of public health is an important policy goal in itself. However, this study suggests that
health improvement of the elderly does not necessarily lead to containment of healthcare costs. Although
speciﬁc health improvements can be cost effective, counting on general trends in health to lower long-term
costs of health care is too optimistic. Interaction between health and mortality, and possible postponement
of costs, should be taken into account when making projections of future costs of health care.
APPENDIX A: REGRESSION TABLES
The regression results for each health indicator are reported in Tables AI–AIV.
Table AI. Regression results of the three-part model for perceived health status, coefﬁcients and p-values
Part 1 Part 2 Part 3
Age Sex Health Coef. p Coef. p Coef. p
t-independent
50–60 M 2  0.48 0.48 0.55 0.00  0.24 0.18
50–60 M 3  2.04 0.00 1.32 0.00 0.06 0.74
50–60 W 1  0.46 0.60 0.04 0.81  0.63 0.01
50–60 W 2 1.38 0.11 0.46 0.00  0.54 0.00
50–60 W 3  1.14 0.10 1.19 0.00  0.01 0.97
60–70 M 1  1.37 0.07 0.67 0.00  0.11 0.62
60–70 M 2  1.53 0.02 0.96 0.00 0.06 0.75
60–70 M 3  2.37 0.00 1.69 0.00 0.42 0.02
60–70 W 1 1.11 0.39 0.61 0.00  0.38 0.11
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Part 1 Part 2 Part 3
Age Sex Health Coef. p Coef. p Coef. p
60–70 W 2  0.37 0.60 0.68 0.00  0.09 0.64
60–70 W 3  1.78 0.01 1.47 0.00 0.08 0.63
70–80 M 1  2.10 0.01 0.94 0.00  0.17 0.49
70–80 M 2  2.37 0.00 1.47 0.00 0.10 0.57
70–80 M 3  3.38 0.00 2.09 0.00 0.43 0.01
70–80 W 1  0.96 0.28 0.70 0.00 0.11 0.70
70–80 W 2  1.87 0.00 1.27 0.00 0.14 0.44
70–80 W 3  2.30 0.00 1.87 0.00 0.31 0.07
480 M 1  3.00 0.00 1.50 0.00 0.30 0.42
480 M 2  3.15 0.00 1.72 0.00 0.11 0.63
480 M 3  3.47 0.00 2.11 0.00 0.54 0.01
480 W 1  2.13 0.02 1.23 0.00 0.30 0.41
480 W 2  2.74 0.00 1.46 0.00 0.17 0.42
480 W 3  3.17 0.00 1.92 0.00 0.44 0.02
t-dependent
50–60 M 1  0.55 0.00 0.14 0.00  0.03 0.55
50–60 M 2  0.47 0.00 0.01 0.49 0.02 0.52
50–60 M 3  0.30 0.00  0.03 0.14 0.02 0.39
50–60 W 1  0.29 0.05 0.04 0.28 0.07 0.15
50–60 W 2  0.63 0.00 0.02 0.24 0.06 0.02
50–60 W 3  0.35 0.00 0.01 0.60  0.01 0.68
60–70 M 1  0.44 0.00 0.07 0.04 0.05 0.30
60–70 M 2  0.49 0.00 0.04 0.01 0.04 0.08
60–70 M 3  0.48 0.00 0.02 0.18  0.01 0.54
60–70 W 1  0.72 0.00 0.02 0.57 0.11 0.09
60–70 W 2  0.55 0.00 0.08 0.00 0.01 0.81
60–70 W 3  0.40 0.00 0.02 0.20 0.04 0.12
70–80 M 1  0.50 0.00 0.12 0.00 0.08 0.14
70–80 M 2  0.56 0.00 0.04 0.06 0.03 0.28
70–80 M 3  0.49 0.00 0.03 0.21  0.01 0.77
70–80 W 1  0.64 0.00 0.16 0.00  0.03 0.71
70–80 W 2  0.43 0.00 0.02 0.29  0.01 0.60
70–80 W 3  0.54 0.00  0.04 0.02  0.01 0.83
480 M 1  0.43 0.00 0.00 0.98  0.01 0.90
480 M 2  0.55 0.00  0.05 0.28 0.04 0.57
480 M 3  0.67 0.00  0.04 0.38 0.00 0.95
480 W 1  0.62 0.00  0.05 0.57  0.01 0.95
480 W 2  0.56 0.00  0.01 0.80 0.07 0.17
480 W 3  0.54 0.00  0.10 0.00  0.02 0.59
1998  0.08 0.25 0.16 0.10
1999  0.96 0.01  0.10 0.13 0.07 0.46
2000  1.44 0.00  0.05 0.41 0.01 0.92
2001  1.52 0.00  0.03 0.58  0.10 0.24
2002  1.64 0.00 0.06 0.33  0.14 0.09
2003  1.81 0.00 0.12 0.05  0.14 0.09
2004  1.85 0.00 0.21 0.00  0.26 0.00
2005  1.00 0.21  0.03 0.83  0.29 0.14
LS 0.29 0.00 0.01 0.70  0.05 0.14
HS 0.22 0.00  0.01 0.67 0.01 0.85
H 0.43 0.00  0.07 0.02  0.20 0.00
c 8.47 0.00  2.76 0.00 8.75 0.00
No. of observations 92680 83010 14684
d.f. 58 59 59
Pseudo R
2 0.258 0.043
Log-likelihood  8830  37076  142511
AIC 17775 74270 285140
BIC 18323 74820 285588
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Part 1 Part 2 Part 3
Age Sex Health Coef. p Coef. p Coef. p








Part 1: logit model of the probability of being alive at the start of period k. Part 2: logit model for the probability of hospital use in
period k conditional on being alive at the start of period k. Part 3: Gamma model for the costs of hospital use in period k
conditional on going to the hospital in period k. Health: 1 excellent health, 2 good health, 3 less than good health. Likelihood ratio
tests: comparison between constant and linear duration dependence, and linear and quadratic duration dependence.
Table AII. Regression results of the three-part model for long-term impairments, coefﬁcients and p-values
Part 1 Part 2 Part 3
Age Sex Health Coef. p Coef. p Coef. p
t-independent
50–60 M 2  0.20 0.66 0.43 0.00  0.11 0.40
50–60 M 3  0.46 0.37 0.72 0.00 0.13 0.37
50–60 W 1 1.25 0.03  0.11 0.20  0.52 0.00
50–60 W 2 1.04 0.14 0.23 0.01  0.27 0.03
50–60 W 3 0.48 0.42 0.68 0.00 0.06 0.63
60–70 M 1  0.71 0.05 0.42 0.00 0.11 0.33
60–70 M 2  0.70 0.07 0.75 0.00 0.31 0.01
60–70 M 3  1.17 0.01 1.13 0.00 0.43 0.00
60–70 W 1 0.21 0.66 0.26 0.00  0.33 0.01
60–70 W 2 0.67 0.23 0.39 0.00  0.05 0.68
60–70 W 3  0.11 0.82 0.94 0.00 0.18 0.17
70–80 M 1  1.28 0.00 0.88 0.00 0.13 0.34
70–80 M 2  1.29 0.00 1.10 0.00 0.24 0.05
70–80 M 3  2.19 0.00 1.50 0.00 0.51 0.00
70–80 W 1  0.70 0.17 0.59 0.00 0.32 0.05
70–80 W 2  0.18 0.69 0.96 0.00 0.06 0.64
70–80 W 3  0.95 0.01 1.20 0.00 0.31 0.01
480 M 1  1.94 0.00 1.31 0.00 0.14 0.60
480 M 2  1.64 0.00 1.53 0.00 0.38 0.05
480 M 3  2.22 0.00 1.57 0.00 0.54 0.00
480 W 1  1.01 0.26 0.90 0.00 0.09 0.79
480 W 2  1.35 0.02 0.85 0.00 0.24 0.36
480 W 3  2.18 0.00 1.26 0.00 0.55 0.00
t-dependent
50–60 M 1  0.36 0.00 0.02 0.35  0.02 0.54
50–60 M 2  0.41 0.00  0.01 0.64 0.02 0.63
50–60 M 3  0.41 0.00  0.01 0.76 0.04 0.33
50–60 W 1  0.51 0.00 0.03 0.17 0.05 0.10
50–60 W 2  0.36 0.01 0.01 0.58 0.05 0.14
50–60 W 3  0.48 0.00 0.02 0.54  0.04 0.29
60–70 M 1  0.46 0.00 0.06 0.00 0.06 0.02
60–70 M 2  0.51 0.00 0.03 0.15  0.01 0.64
60–70 M 3  0.49 0.00  0.02 0.54 0.00 0.93
60–70 W 1  0.50 0.00 0.06 0.01 0.06 0.06
60–70 W 2  0.58 0.00 0.08 0.00 0.04 0.17
60–70 W 3  0.57 0.00 0.04 0.10 0.05 0.15
70–80 M 1  0.57 0.00 0.08 0.00 0.06 0.11
70–80 M 2  0.56 0.00 0.04 0.10 0.03 0.33
70–80 M 3  0.59 0.00 0.05 0.10  0.01 0.69
70–80 W 1  0.41 0.00 0.08 0.01  0.07 0.09
70–80 W 2  0.64 0.00  0.03 0.22 0.04 0.29
70–80 W 3  0.58 0.00  0.03 0.25 0.02 0.51
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Part 1 Part 2 Part 3
Age Sex Health Coef. p Coef. p Coef. p
480 M 1  0.49 0.00  0.01 0.84  0.06 0.54
480 M 2  0.67 0.00  0.14 0.02 0.06 0.47
480 M 3  0.67 0.00  0.01 0.89  0.02 0.78
480 W 1  0.59 0.00  0.05 0.59 0.07 0.47
480 W 2  0.56 0.00  0.07 0.32 0.08 0.38
480 W 3  0.53 0.00  0.05 0.18  0.02 0.72
1998  0.07 0.41 0.17 0.10
1999  1.29 0.02  0.08 0.26 0.08 0.42
2000  1.68 0.00  0.03 0.64  0.01 0.92
2001  1.75 0.00  0.04 0.58  0.17 0.08
2002  1.75 0.00 0.06 0.37  0.15 0.12
2003  1.92 0.00 0.12 0.08  0.19 0.04
2004  1.92 0.00 0.21 0.00  0.30 0.00
2005  1.55 0.08 0.03 0.87  0.23 0.27
LS 0.27 0.00  0.05 0.09  0.02 0.57
HS 0.21 0.00  0.06 0.05 0.00 0.95
H 0.47 0.00  0.14 0.00  0.19 0.00
c 7.67 0.00  2.23 0.00 8.69 0.00
No. of observations 72433 65129 11192
d.f. 58 59 59
Pseudo R
2 0.246 0.034
Log-likelihood  6060  28876  108069
AIC 12236 57870 216256
BIC 12770 58406 216688








Part 1: logit model of the probability of being alive at the start of period k. Part 2: logit model for the probability of hospital use in
period k conditional on being alive at the start of period k. Part 3: Gamma model for the costs of hospital use in period k conditional
on going to the hospital in period k. Health: 1 no difﬁculty, 2 at least one minor and no major difﬁculty, 3 at leastone major difﬁculty.
Likelihood Ratio tests: comparison between constant and linear duration dependence, and linear and quadratic duration dependence.
Table AIII. Regression results of the three-part model for ADL limitations, coefﬁcients and p-values
Part 1 Part 2 Part 3
Age Sex Health Coef. p Coef. p Coef. p
t-independent
50–60 M 2  0.44 0.00 0.57 0.00 0.34 0.05
50–60 M 3  0.44 0.00 1.07 0.00 0.26 0.27
50–60 W 1  0.26 0.10  0.17 0.03  0.33 0.00
50–60 W 2  0.50 0.00 0.30 0.01  0.20 0.25
50–60 W 3  0.19 0.48 1.09 0.00 0.72 0.00
60–70 M 1  0.20 0.13 0.29 0.00 0.20 0.04
60–70 M 2  0.48 0.00 0.93 0.00 0.48 0.00
60–70 M 3  0.49 0.00 1.52 0.00 0.53 0.00
60–70 W 1  0.55 0.00 0.11 0.14  0.07 0.51
60–70 W 2  0.53 0.00 0.55 0.00 0.08 0.54
60–70 W 3  0.44 0.00 1.07 0.00 0.42 0.00
70–80 M 1  0.38 0.00 0.80 0.00 0.20 0.04
70–80 M 2  0.51 0.00 1.15 0.00 0.32 0.01
70–80 M 3  0.53 0.00 1.67 0.00 0.75 0.00
70–80 W 1  0.61 0.00 0.53 0.00 0.16 0.14
70–80 W 2  0.52 0.00 1.03 0.00 0.41 0.00
70–80 W 3  0.52 0.00 1.26 0.00 0.43 0.00
480 M 1  0.52 0.00 0.92 0.00 0.18 0.29
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Age Sex Health Coef. p Coef. p Coef. p
480 M 2  0.50 0.00 1.35 0.00 0.41 0.02
480 M 3  0.59 0.00 1.48 0.00 0.71 0.00
480 W 1  0.84 0.00 0.73 0.00 0.18 0.29
480 W 2  0.62 0.00 0.88 0.00 0.38 0.02
480 W 3  0.47 0.00 1.23 0.00 0.53 0.00
t-dependent
50–60 M 1  0.60 0.00 0.03 0.10 0.00 0.99
50–60 M 2  0.43 0.46  0.01 0.78  0.09 0.09
50–60 M 3  1.70 0.01 0.04 0.53 0.12 0.11
50–60 W 1 1.25 0.02 0.03 0.09 0.08 0.00
50–60 W 2 0.81 0.46 0.05 0.14 0.02 0.75
50–60 W 3  1.41 0.02  0.02 0.70  0.15 0.01
60–70 M 1  0.52 0.09 0.06 0.00 0.03 0.13
60–70 M 2  1.37 0.00 0.02 0.46  0.02 0.53
60–70 M 3  1.70 0.00  0.02 0.58 0.02 0.59
60–70 W 1 0.56 0.14 0.05 0.00 0.02 0.30
60–70 W 2  0.30 0.51 0.07 0.01 0.05 0.10
60–70 W 3  1.39 0.00 0.03 0.36 0.03 0.39
70–80 M 1  1.46 0.00 0.05 0.01 0.04 0.09
70–80 M 2  2.05 0.00 0.06 0.07 0.04 0.31
70–80 M 3  2.55 0.00 0.05 0.22  0.07 0.09
70–80 W 1  0.61 0.07 0.05 0.01 0.01 0.57
70–80 W 2  0.95 0.01  0.04 0.07  0.05 0.11
70–80 W 3  1.62 0.00  0.04 0.10 0.00 0.93
480 M 1  2.15 0.00  0.01 0.79 0.02 0.71
480 M 2  2.22 0.00  0.05 0.32 0.04 0.58
480 M 3  2.26 0.00  0.05 0.49 0.02 0.83
480 W 1  1.17 0.01  0.03 0.54 0.04 0.51
480 W 2  1.79 0.00  0.01 0.76 0.03 0.61
480 W 3  2.23 0.00  0.11 0.00 0.00 0.93
1998  0.07 0.38 0.14 0.14
1999  0.93 0.02  0.12 0.09 0.09 0.36
2000  1.40 0.00  0.05 0.43 0.01 0.91
2001  1.44 0.00  0.04 0.50  0.12 0.19
2002  1.53 0.00 0.05 0.45  0.14 0.09
2003  1.71 0.00 0.09 0.16  0.16 0.07
2004  1.76 0.00 0.18 0.01  0.27 0.00
2005  0.99 0.21 0.04 0.81  0.31 0.12
LS 0.27 0.00 0.01 0.80  0.07 0.04
HS 0.16 0.01  0.02 0.52 0.00 0.95
H 0.41 0.00  0.08 0.01  0.20 0.00
c 7.38 0.00  2.06 0.00 8.68 0.00
No. of observations 74871 67459 12884
d.f. 58 59 59
Pseudo R
2 0.255 0.035
Log-likelihood  8161  31753  125602
AIC 16438 63624 251324
BIC 16973 64162 251959








Part 1: logit model of the probability of being alive at the start of period k. Part 2: logit model for the probability of hospital use in
period k conditional on being alive at the start of period k. Part 3: Gamma model for the costs of hospital use in period k
conditional on going to the hospital in period k. Health: 1 no difﬁculty, 2 at least one minor and no major difﬁculty, 3 at least one
major difﬁculty. Likelihood Ratio tests: comparison between constant and linear duration dependence, and linear and quadratic
duration dependence.
RELATIONSHIP BETWEEN BASELINE HEALTH AND COST
Copyright r 2010 John Wiley & Sons, Ltd. Health Econ. (2010)
DOI: 10.1002/hecTable AIV. Regression results of the three-part model for comorbidity, coefﬁcients and p-values
Part 1 Part 2 Part 3
Age Sex Health Coef. p Coef. p Coef. p
t-independent
50–60 M 2  0.32 0.47 0.45 0.00  0.06 0.64
50–60 M 3  0.52 0.31 0.72 0.00  0.01 0.93
50–60 W 1 1.18 0.04  0.14 0.12  0.34 0.01
50–60 W 2 1.57 0.04 0.29 0.00  0.27 0.04
50–60 W 3 0.44 0.47 0.59 0.00  0.22 0.09
60–70 M 1  0.69 0.07 0.43 0.00 0.22 0.07
60–70 M 2  0.59 0.15 0.68 0.00 0.27 0.03
60–70 M 3  1.67 0.00 1.24 0.00 0.29 0.02
60–70 W 1  0.11 0.82 0.15 0.11  0.13 0.34
60–70 W 2 0.65 0.27 0.41 0.00  0.02 0.87
60–70 W 3  0.08 0.86 0.91 0.00  0.03 0.81
70–80 M 1  1.30 0.00 0.87 0.00 0.11 0.43
70–80 M 2  1.71 0.00 1.16 0.00 0.46 0.00
70–80 M 3  2.15 0.00 1.57 0.00 0.22 0.10
70–80 W 1  0.64 0.17 0.44 0.00 0.27 0.09
70–80 W 2  1.09 0.01 1.01 0.00 0.16 0.26
70–80 W 3  0.48 0.25 1.25 0.00 0.27 0.03
480 M 1  1.29 0.02 1.23 0.00 0.35 0.10
480 M 2  2.28 0.00 1.71 0.00 0.52 0.01
480 M 3  2.40 0.00 1.70 0.00 0.64 0.01
480 W 1  1.11 0.06 0.96 0.00 0.29 0.23
480 W 2  2.32 0.00 1.16 0.00 0.50 0.01
480 W 3  1.92 0.00 1.33 0.00 0.47 0.01
t-dependent
50–60 M 1  0.37 0.00 0.02 0.44  0.05 0.09
50–60 M 2  0.41 0.00  0.01 0.79 0.03 0.29
50–60 M 3  0.40 0.00  0.02 0.45 0.08 0.06
50–60 W 1  0.51 0.00 0.02 0.37 0.03 0.27
50–60 W 2  0.57 0.00 0.01 0.61 0.04 0.24
50–60 W 3  0.41 0.00 0.03 0.15 0.01 0.86
60–70 M 1  0.46 0.00 0.04 0.07 0.01 0.74
60–70 M 2  0.58 0.00 0.05 0.02 0.01 0.63
60–70 M 3  0.36 0.00 0.01 0.60 0.02 0.61
60–70 W 1  0.46 0.00 0.02 0.32 0.02 0.61
60–70 W 2  0.59 0.00 0.05 0.03 0.01 0.77
60–70 W 3  0.56 0.00 0.08 0.00 0.06 0.03
70–80 M 1  0.53 0.00 0.03 0.31 0.05 0.16
70–80 M 2  0.54 0.00 0.08 0.00  0.01 0.77
70–80 M 3   0.59 0.00 0.05 0.12 0.07 0.07
70–80 W 1  0.52 0.00 0.07 0.02  0.01 0.77
70–80 W 2  0.44 0.00  0.03 0.31 0.01 0.75
70–80 W 3  0.68 0.00 0.00 1.00 0.00 0.99
480 M 1  0.64 0.00  0.04 0.51  0.05 0.49
480 M 2  0.59 0.00  0.04 0.52  0.04 0.56
480 M 3  0.79 0.00  0.06 0.46  0.06 0.60
480 W 1  0.61 0.00  0.03 0.55 0.04 0.57
480 W 2  0.55 0.00  0.07 0.26  0.04 0.55
480 W 3  0.55 0.00  0.04 0.42 0.03 0.68
1998  0.09 0.29 0.16 0.15
1999  0.93 0.06  0.09 0.22 0.09 0.37
2000  1.41 0.00  0.04 0.61  0.01 0.95
2001  1.53 0.00  0.05 0.52  0.13 0.19
2002  1.49 0.00 0.03 0.63  0.16 0.09
2003  1.67 0.00 0.10 0.18  0.19 0.05
2004  1.68 0.00 0.19 0.01  0.27 0.01
2005  1.24 0.14 0.02 0.92  0.24 0.25
LS 0.33 0.00  0.06 0.03  0.05 0.20
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